Bjoern Meyer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bjoern Meyer

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Nature Communications|April 17, 2021

Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hostsVeronica V Rezelj, Lucía Carrau, Fernando Merwaiss, et al.

Science (New York, N.Y.)|July 21, 2021

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.

Cell|July 10, 2020

The Global Phosphorylation Landscape of SARS-CoV-2 InfectionMehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.

Nature|May 1, 2020

A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Nature Communications|April 17, 2021

Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hostsVeronica V Rezelj, Lucía Carrau, Fernando Merwaiss, et al.

Science (New York, N.Y.)|July 21, 2021

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.

Cell|July 10, 2020

The Global Phosphorylation Landscape of SARS-CoV-2 InfectionMehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.

Nature|May 1, 2020

A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.

Pageof 3